{"count": 106, "results": [{"_id": "34983571", "pmid": 34983571, "pmcid": "PMC8729102", "title": "Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients", "journal": "Reprod Biol Endocrinol", "authors": ["Garzia E", "Galiano V", "Marfia G", "Navone S", "Grossi E", "Marconi AM"], "date": "2022-01-04T00:00:00Z", "doi": "10.1186/s12958-021-00876-0", "meta_date_publication": "2022 Jan 4", "meta_volume": "20", "meta_issue": "1", "meta_pages": "6", "score": 50282.562, "text_hl": "@<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@Hyperandrogenism@@@ and menstrual imbalance are the best predictors of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ response in @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ patients", "citations": {"NLM": "Garzia E, Galiano V, Marfia G, Navone S, Grossi E, Marconi AM. Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients Reprod Biol Endocrinol. 2022 Jan 4;20(1):6. PMID: 34983571", "BibTeX": "@article{34983571, title={Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients}, author={Garzia E and Galiano V and Marfia G and Navone S and Grossi E and Marconi AM}, journal={Reprod Biol Endocrinol}, volume={20}, number={1}, pages={6}}"}}, {"_id": "36299963", "pmid": 36299963, "pmcid": "PMC9588252", "title": "A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills", "journal": "Cureus", "authors": ["Fattah A", "Al-Kader DA", "Jones Amaowei EE", "Amini H", "Hewadmal H", "Rasuli SF", "Ikedum IV", "Farooq J", "Bashar M", "Qadar LT"], "date": "2022-09-23T00:00:00Z", "doi": "10.7759/cureus.29487", "meta_date_publication": "2022 Sep", "meta_volume": "14", "meta_issue": "9", "meta_pages": "e29487", "score": 50278.156, "text_hl": "The primary objective of the study was to compare the serum luteinizing hormone (LH) levels in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@hyperandrogenism@@@ on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and combined oral contraceptive pills. ", "citations": {"NLM": "Fattah A, Al-Kader DA, Jones Amaowei EE, Amini H, Hewadmal H, Rasuli SF, Ikedum IV, Farooq J, Bashar M, Qadar LT. A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills Cureus. 2022 Sep;14(9):e29487. PMID: 36299963", "BibTeX": "@article{36299963, title={A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills}, author={Fattah A and Al-Kader DA and Jones Amaowei EE and Amini H and Hewadmal H and Rasuli SF and Ikedum IV and Farooq J and Bashar M and Qadar LT}, journal={Cureus}, volume={14}, number={9}, pages={e29487}}"}}, {"_id": "34830216", "pmid": 34830216, "pmcid": "PMC8620117", "title": "Hyperandrogenism? Increased 17, 20-Lyase Activity? A Metanalysis and Systematic Review of Altered Androgens in Boys and Girls with Autism", "journal": "Int J Mol Sci", "authors": ["Gasser BA", "Buerki SF", "Kurz J", "Mohaupt MG"], "date": "2021-11-15T00:00:00Z", "doi": "10.3390/ijms222212324", "meta_date_publication": "2021 Nov 15", "meta_volume": "22", "meta_issue": "22", "meta_pages": "", "score": 50275.824, "text_hl": "As previously suggested, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, which is already efficiently being used in @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@hyperandrogenism@@@ due to @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@, reduces oxidative stress and @<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@hyperandrogenism@@@ and, as such, this might be one pharmacological target.", "citations": {"NLM": "Gasser BA, Buerki SF, Kurz J, Mohaupt MG. Hyperandrogenism? Increased 17, 20-Lyase Activity? A Metanalysis and Systematic Review of Altered Androgens in Boys and Girls with Autism Int J Mol Sci. 2021 Nov 15;22(22):. PMID: 34830216", "BibTeX": "@article{34830216, title={Hyperandrogenism? Increased 17, 20-Lyase Activity? A Metanalysis and Systematic Review of Altered Androgens in Boys and Girls with Autism}, author={Gasser BA and Buerki SF and Kurz J and Mohaupt MG}, journal={Int J Mol Sci}, volume={22}, number={22}}"}}, {"_id": "32866967", "pmid": 32866967, "pmcid": "PMC7538101", "title": "Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus", "journal": "J Clin Endocrinol Metab", "authors": ["Andræ F", "Abbott D", "Stridsklev S", "Schmedes AV", "Odsæter IH", "Vanky E", "Salvesen Ø"], "date": "2020-12-01T00:00:00Z", "doi": "10.1210/clinem/dgaa605", "meta_date_publication": "2020 Dec 1", "meta_volume": "105", "meta_issue": "12", "meta_pages": "3762-70", "score": 50275.3, "text_hl": "Sustained @<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@Maternal Hyperandrogenism@@@ During @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ Pregnancy Reduced by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in Non-@DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @SPECIES_9606 @@@Women@@@ Carrying a Male Fetus", "citations": {"NLM": "Andræ F, Abbott D, Stridsklev S, Schmedes AV, Odsæter IH, Vanky E, Salvesen Ø. Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus J Clin Endocrinol Metab. 2020 Dec 1;105(12):3762-70. PMID: 32866967", "BibTeX": "@article{32866967, title={Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus}, author={Andræ F and Abbott D and Stridsklev S and Schmedes AV and Odsæter IH and Vanky E and Salvesen Ø}, journal={J Clin Endocrinol Metab}, volume={105}, number={12}, pages={3762-70}}"}}, {"_id": "34787028", "pmid": 34787028, "title": "Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance.", "journal": "Gynecol Endocrinol", "authors": ["Hernández-Jiménez JL", "Barrera D", "Espinoza-Simón E", "González J", "Ortíz-Hernández R", "Escobar L", "Echeverría O", "Torres-Ramírez N"], "date": "2022-01-01T00:00:00Z", "doi": "10.1080/09513590.2021.2003326", "meta_date_publication": "2022 Jan", "meta_volume": "38", "meta_issue": "1", "meta_pages": "2-9", "score": 50266.676, "text_hl": "Therefore, we propose that treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could decrease @DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@HI@@@ and consequently @<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@HA@@@, restoring, at least in part, the @DISEASE_Thyroid_Hormone_Metabolism_Abnormal @DISEASE_MESH:C566454 @@@metabolic and hormonal disorders@@@ of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@.", "citations": {"NLM": "Hernández-Jiménez JL, Barrera D, Espinoza-Simón E, González J, Ortíz-Hernández R, Escobar L, Echeverría O, Torres-Ramírez N. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2022 Jan;38(1):2-9. PMID: 34787028", "BibTeX": "@article{34787028, title={Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance.}, author={Hernández-Jiménez JL and Barrera D and Espinoza-Simón E and González J and Ortíz-Hernández R and Escobar L and Echeverría O and Torres-Ramírez N}, journal={Gynecol Endocrinol}, volume={38}, number={1}, pages={2-9}}"}}, {"_id": "36763111", "pmid": 36763111, "title": "Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.", "journal": "Eur J Clin Pharmacol", "authors": ["Fontes AFS", "Reis FM", "Cândido AL", "Gomes KB", "Tosatti JAG"], "date": "2023-04-01T00:00:00Z", "doi": "10.1007/s00228-023-03461-z", "meta_date_publication": "2023 Apr", "meta_volume": "79", "meta_issue": "4", "meta_pages": "445-460", "score": 50265.766, "text_hl": "Influence of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@hyperandrogenism@@@ in @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@: a systematic review and meta-analysis of randomized clinical trials.", "citations": {"NLM": "Fontes AFS, Reis FM, Cândido AL, Gomes KB, Tosatti JAG. Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. Eur J Clin Pharmacol. 2023 Apr;79(4):445-460. PMID: 36763111", "BibTeX": "@article{36763111, title={Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.}, author={Fontes AFS and Reis FM and Cândido AL and Gomes KB and Tosatti JAG}, journal={Eur J Clin Pharmacol}, volume={79}, number={4}, pages={445-460}}"}}, {"_id": "34752810", "pmid": 34752810, "title": "The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.", "journal": "Steroids", "authors": ["Mahmoud AA", "Elfiky AM", "Abo-Zeid FS"], "date": "2022-01-01T00:00:00Z", "doi": "10.1016/j.steroids.2021.108936", "meta_date_publication": "2022 Jan", "meta_volume": "177", "meta_issue": "", "meta_pages": "108936", "score": 50262.168, "text_hl": "Our study revealed that @CHEMICAL_Glutamine @CHEMICAL_MESH:D005973 @@@Q@@@ is as effective as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ in reducing @<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@hyperandrogenism@@@ via decreasing free T level and improving hypothalamic-pituitary-ovarian axis function. ", "citations": {"NLM": "Mahmoud AA, Elfiky AM, Abo-Zeid FS. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome. Steroids. 2022 Jan;177():108936. PMID: 34752810", "BibTeX": "@article{34752810, title={The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.}, author={Mahmoud AA and Elfiky AM and Abo-Zeid FS}, journal={Steroids}, volume={177}, pages={108936}}"}}, {"_id": "36176868", "pmid": 36176868, "pmcid": "PMC9511677", "title": "Role of Metformin in the Management of Polycystic Ovarian Syndrome-Associated Acne: A Systematic Review", "journal": "Cureus", "authors": ["Shamim H", "Jean M", "Umair M", "Muddaloor P", "Farinango M", "Ansary A", "Dakka A", "Nazir Z", "White CT", "Habbal AB", "Mohammed L"], "date": "2022-08-27T00:00:00Z", "doi": "10.7759/cureus.28462", "meta_date_publication": "2022 Aug", "meta_volume": "14", "meta_issue": "8", "meta_pages": "e28462", "score": 50262.156, "text_hl": "Using the MeSH search function, the keywords \"@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovarian syndrome@@@\", \"@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@\", \"@<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@hyperandrogenism@@@\", and \"@DISEASE_Acne_Vulgaris @DISEASE_MESH:D000152 @@@acne@@@\" were used.", "citations": {"NLM": "Shamim H, Jean M, Umair M, Muddaloor P, Farinango M, Ansary A, Dakka A, Nazir Z, White CT, Habbal AB, Mohammed L. Role of Metformin in the Management of Polycystic Ovarian Syndrome-Associated Acne: A Systematic Review Cureus. 2022 Aug;14(8):e28462. PMID: 36176868", "BibTeX": "@article{36176868, title={Role of Metformin in the Management of Polycystic Ovarian Syndrome-Associated Acne: A Systematic Review}, author={Shamim H and Jean M and Umair M and Muddaloor P and Farinango M and Ansary A and Dakka A and Nazir Z and White CT and Habbal AB and Mohammed L}, journal={Cureus}, volume={14}, number={8}, pages={e28462}}"}}, {"_id": "32067218", "pmid": 32067218, "title": "Decreased Circulating MANF in Women with PCOS is Elevated by Metformin Therapy and is Inversely Correlated with Insulin Resistance and Hyperandrogenism.", "journal": "Horm Metab Res", "authors": ["Wei J", "Wang C", "Yang G", "Jia Y", "Li Y", "Deng W", "Long M", "Wang C", "Liu D"], "date": "2020-02-01T00:00:00Z", "doi": "10.1055/a-1082-1080", "meta_date_publication": "2020 Feb", "meta_volume": "52", "meta_issue": "2", "meta_pages": "109-116", "score": 50260.62, "text_hl": "Decreased Circulating @GENE_MANF @GENE_7873 @@@MANF@@@ in @SPECIES_9606 @@@Women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ is Elevated by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Therapy and is Inversely Correlated with @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@Insulin Resistance@@@ and @<m>DISEASE_Hyperandrogenism</m> @DISEASE_MESH:D017588 @@@Hyperandrogenism@@@.", "citations": {"NLM": "Wei J, Wang C, Yang G, Jia Y, Li Y, Deng W, Long M, Wang C, Liu D. Decreased Circulating MANF in Women with PCOS is Elevated by Metformin Therapy and is Inversely Correlated with Insulin Resistance and Hyperandrogenism. Horm Metab Res. 2020 Feb;52(2):109-116. PMID: 32067218", "BibTeX": "@article{32067218, title={Decreased Circulating MANF in Women with PCOS is Elevated by Metformin Therapy and is Inversely Correlated with Insulin Resistance and Hyperandrogenism.}, author={Wei J and Wang C and Yang G and Jia Y and Li Y and Deng W and Long M and Wang C and Liu D}, journal={Horm Metab Res}, volume={52}, number={2}, pages={109-116}}"}}, {"_id": "38131036", "pmid": 38131036, "pmcid": "PMC10735721", "title": "Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients", "journal": "Int J Endocrinol", "authors": ["Gan J", "Chen J", "Ma RL", "Deng Y", "Ding XS", "Zhu SY", "Sun AJ"], "date": "2023-12-14T00:00:00Z", "doi": "10.1155/2023/4288004", "meta_date_publication": "2023", "meta_volume": "2023", "meta_issue": "", "meta_pages": "4288004", "score": 50259.145, "text_hl": "Action Mechanisms of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Combined with @CHEMICAL_Exenatide @CHEMICAL_MESH:D000077270 @@@Exenatide@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Only in the Treatment of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ in Obese Patients", "citations": {"NLM": "Gan J, Chen J, Ma RL, Deng Y, Ding XS, Zhu SY, Sun AJ. Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients Int J Endocrinol. 2023;2023():4288004. PMID: 38131036", "BibTeX": "@article{38131036, title={Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients}, author={Gan J and Chen J and Ma RL and Deng Y and Ding XS and Zhu SY and Sun AJ}, journal={Int J Endocrinol}, volume={2023}, pages={4288004}}"}}]}